| scholarly article | Q13442814 |
| P2093 | author name string | Arunmozhiarasi Armugam | |
| Kandiah Jeyaseelan | |||
| Kai Ying Lim | |||
| P2860 | cites work | Post-transcriptional regulation of the let-7 microRNA during neural cell specification | Q28278730 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microRNA expression | Q60681249 |
| P304 | page(s) | 959-966 | |
| P577 | publication date | 2008-02-07 | |
| P1433 | published in | Stroke Journal | Q7624282 |
| P1476 | title | MicroRNA expression in the blood and brain of rats subjected to transient focal ischemia by middle cerebral artery occlusion | |
| P478 | volume | 39 |
| Q52360905 | A Novel Five-Node Feed-Forward Loop Unravels miRNA-Gene-TF Regulatory Relationships in Ischemic Stroke. |
| Q48243404 | A functional variant in the 3'-UTR of angiopoietin-1 might reduce stroke risk by interfering with the binding efficiency of microRNA 211. |
| Q37180715 | Aberration of miRNAs Expression in Leukocytes from Sporadic Amyotrophic Lateral Sclerosis |
| Q33431121 | Acute vascular disruption and aquaporin 4 loss after stroke |
| Q26827622 | Advances in astrocyte-targeted approaches for stroke therapy: an emerging role for mitochondria and microRNAS |
| Q27012757 | All's well that transcribes well: non-coding RNAs and post-stroke brain damage |
| Q43202510 | Altered expression of PIWI RNA in the rat brain after transient focal ischemia |
| Q38864252 | Amikacin Inhibits miR-497 Maturation and Exerts Post-ischemic Neuroprotection. |
| Q39882287 | An Antagomir to MicroRNA-106b-5p Ameliorates Cerebral Ischemia and Reperfusion Injury in Rats Via Inhibiting Apoptosis and Oxidative Stress |
| Q34185984 | An antagomir to microRNA Let7f promotes neuroprotection in an ischemic stroke model |
| Q48567965 | An rs13293512 polymorphism in the promoter of let-7 is associated with a reduced risk of ischemic stroke |
| Q35626122 | An updated role of microRNA-124 in central nervous system disorders: a review |
| Q47939843 | Analysis of long non-coding RNA expression profiles following focal cerebral ischemia in mice |
| Q85559287 | Angiogenesis-regulating microRNAs and Ischemic Stroke |
| Q55003673 | Association of MicroRNA Biogenesis Genes Polymorphisms with Ischemic Stroke Susceptibility and Post-Stroke Mortality. |
| Q48232363 | Association of MicroRNA-146a and MicroRNA-149 Polymorphisms With Strokes in Asian Populations: An Updated Meta-Analysis |
| Q33621219 | Association of microRNA-related gene XPO5 rs11077 polymorphism with susceptibility to thyroid cancer |
| Q36939169 | Association of the MicroRNA-146a SNP rs2910164 with Ischemic Stroke Incidence and Prognosis in a Chinese Population |
| Q37261050 | Astrocyte-enriched miR-29a targets PUMA and reduces neuronal vulnerability to forebrain ischemia |
| Q33726703 | Attenuated neuroprotective effect of riboflavin under UV-B irradiation via miR-203/c-Jun signaling pathway in vivo and in vitro |
| Q33566724 | Beneficial effects of mood stabilizers lithium, valproate and lamotrigine in experimental stroke models |
| Q50053755 | Bioinformatic analysis of gene expression profiles of pituitary gonadotroph adenomas |
| Q92628583 | Bioinformatics analysis of a long non‑coding RNA and mRNA regulation network in rats with middle cerebral artery occlusion based on RNA sequencing |
| Q35117479 | Blood brain barrier and neuroinflammation are critical targets of IGF-1-mediated neuroprotection in stroke for middle-aged female rats |
| Q28070302 | Blood microRNAs as potential diagnostic and prognostic markers in cerebral ischemic injury |
| Q37655630 | Blood microRNAs as potential diagnostic markers for hemorrhagic stroke |
| Q36590184 | Blood microRNAs in low or no risk ischemic stroke patients |
| Q34170732 | Brain and blood microRNA expression profiling of ischemic stroke, intracerebral hemorrhage, and kainate seizures. |
| Q47624437 | Brain-immune interactions in perinatal hypoxic-ischemic brain injury. |
| Q37524901 | Cell biology of ischemia/reperfusion injury |
| Q35137635 | Central nervous system agents for ischemic stroke: neuroprotection mechanisms |
| Q50351165 | Characterization of extracellular vesicles derived from cardiac cells in an in vitro model of preconditioning. |
| Q90346193 | Circular RNA expression profile in blood according to ischemic stroke etiology |
| Q64245284 | Circulating MiRNA-195-5p and -451a in Transient and Acute Ischemic Stroke Patients in an Emergency Department |
| Q26800274 | Circulating MicroRNAs: Potential and Emerging Biomarkers for Diagnosis of Cardiovascular and Cerebrovascular Diseases |
| Q48117615 | Circulating miR-145 is associated with plasma high-sensitivity C-reactive protein in acute ischemic stroke patients |
| Q35044246 | Circulating miR-30a, miR-126 and let-7b as biomarker for ischemic stroke in humans |
| Q35282066 | Circulating miRNA profiles provide a biomarker for severity of stroke outcomes associated with age and sex in a rat model |
| Q38045189 | Circulating miRNAs: reflecting or affecting cardiovascular disease? |
| Q35870820 | Circulating microRNA 132-3p and 324-3p Profiles in Patients after Acute Aneurysmal Subarachnoid Hemorrhage |
| Q86809686 | Circulating microRNAs as Biomarkers in Cardiovascular Diseases |
| Q37535652 | Circulating microRNAs as biomarkers of acute stroke |
| Q38153192 | Circulating microRNAs as potential non-invasive biomarkers for the early detection of hypertension-related stroke |
| Q37967181 | Circulating microRNAs: novel biomarkers for cardiovascular diseases |
| Q48123880 | Circulating pro-angiogenic and anti-angiogenic microRNA expressions in patients with acute ischemic stroke and their association with disease severity. |
| Q33989539 | Decreased DGCR8 expression and miRNA dysregulation in individuals with 22q11.2 deletion syndrome |
| Q54420834 | Detection of differentially expressed microRNAs in serum of pancreatic ductal adenocarcinoma patients: miR-196a could be a potential marker for poor prognosis. |
| Q27022987 | Developing epigenetic diagnostics and therapeutics for brain disorders |
| Q38737886 | Development and regulation of exosome-based therapy products |
| Q42646979 | Diagnosing and Treating Nervous System Disorders by Targeting Novel Classes of Non-coding RNAs |
| Q47895437 | Downregulation of miR-181b in mouse brain following ischemic stroke induces neuroprotection against ischemic injury through targeting heat shock protein A5 and ubiquitin carboxyl-terminal hydrolase isozyme L1. |
| Q41660873 | Dual Role of MiR-21-Mediated Signaling in HUVECs and Rat Surgical Flap under Normoxia and Hypoxia Condition |
| Q92493187 | Dysregulation of microRNA metabolism in motor neuron diseases: Novel biomarkers and potential therapeutics |
| Q37971391 | E2F and microRNA regulation of angiogenesis. |
| Q36542634 | Early diagnosis of Alzheimer's disease from elevated olfactory mucosal miR-206 level. |
| Q37204527 | Effect of baicalin on hippocampal damage in kainic acid-induced epileptic mice |
| Q38268937 | Effect of sex and age interactions on functional outcome after stroke |
| Q52148640 | Effects of acupuncture at Baihui (GV 20) and Zusanli (ST 36) on peripheral serum expression of MicroRNA 124, laminin and integrin β1 in rats with cerebral ischemia reperfusion injury. |
| Q48192200 | Effects of low temperatures on proliferation-related signaling pathways in the hippocampus after traumatic brain injury |
| Q37609958 | Electroacupuncture induces acute changes in cerebral cortical miRNA profile, improves cerebral blood flow and alleviates neurological deficits in a rat model of stroke. |
| Q48164145 | Elevated plasma CaM expression in patients with acute cerebral infarction predicts poor outcomes and is inversely associated with miR-26b expression |
| Q33893145 | Elevation of brain-enriched miRNAs in cerebrospinal fluid of patients with acute ischemic stroke |
| Q64107024 | Emerging Roles of miRNAs in Brain Development and Perinatal Brain Injury |
| Q33783563 | Emerging Roles of microRNAs in Ischemic Stroke: As Possible Therapeutic Agents |
| Q36567408 | Emerging molecular targets for brain repair after stroke |
| Q34289150 | Emerging roles of non-coding RNAs in brain evolution, development, plasticity and disease |
| Q21257177 | Entrapment neuropathy results in different microRNA expression patterns from denervation injury in rats |
| Q99634731 | Epigenetic Mechanisms Underlying Adult Post Stroke Neurogenesis |
| Q26995412 | Epigenetic impact of curcumin on stroke prevention |
| Q36405886 | Epigenetic mechanisms governing the process of neurodegeneration |
| Q37137442 | Epigenetics, nervous system tumors, and cancer stem cells |
| Q33633968 | Exosome Mediated Delivery of miR-124 Promotes Neurogenesis after Ischemia |
| Q34481082 | Exosomes/miRNAs as mediating cell-based therapy of stroke |
| Q48351519 | Expression of NMDA receptor and microRNA-219 in rats submitted to cerebral ischemia associated with alcoholism |
| Q33514818 | Expression profile of MicroRNAs in young stroke patients |
| Q35123801 | Expression profiles of microRNAs after focal cerebral ischemia/reperfusion injury in rats |
| Q33952516 | Expression profiling of RNA transcripts during neuronal maturation and ischemic injury |
| Q26767270 | Focus on Extracellular Vesicles: Physiological Role and Signalling Properties of Extracellular Membrane Vesicles |
| Q33834655 | Functional annotation of Alzheimer's disease associated loci revealed by GWASs. |
| Q36474007 | Gene expression profiling in stroke: relevance of blood-brain interaction |
| Q48901579 | Genetic polymorphisms in pre-microRNAs and risk of ischemic stroke in a Chinese population |
| Q38061499 | Genetics and genomics of ischemic tolerance: focus on cardiac and cerebral ischemic preconditioning |
| Q37441257 | Genetics of stroke |
| Q40689258 | Genome-wide identification of microRNA-related variants associated with risk of Alzheimer's disease |
| Q37473789 | Genomics, transcriptional profiling, and heart failure |
| Q44833373 | Growth of malignant extracranial tumors alters microRNAome in the prefrontal cortex of TumorGraft mice |
| Q39458308 | Hypoxia in CNS Pathologies: Emerging Role of miRNA-Based Neurotherapeutics and Yoga Based Alternative Therapies |
| Q37215302 | Hypoxia response and microRNAs: no longer two separate worlds. |
| Q92258077 | Hypoxia-Induced miR-210 Is Necessary for Vascular Regeneration upon Acute Limb Ischemia |
| Q34082176 | Hypoxia-induced miR-210 modulates tissue response to acute peripheral ischemia |
| Q36247404 | Identification and Functional Analysis of MicroRNAs in Mice following Focal Cerebral Ischemia Injury |
| Q40828673 | Identification of Biomarkers Associated With Alzheimer's Disease by Bioinformatics Analysis |
| Q36173055 | Identification of Blood Let-7e-5p as a Biomarker for Ischemic Stroke |
| Q38470339 | Identification of circulating microRNAs as potential biomarkers for detecting acute ischemic stroke |
| Q39428035 | Identification of differentially expressed microRNAs and their PKC-isoform specific gene network prediction during hypoxic pre-conditioning and focal cerebral ischemia of mice |
| Q33739701 | Identification of miRNomes associated with adult neurogenesis after stroke using Argonaute 2-based RNA sequencing |
| Q39037754 | Implications of Epigenetic Mechanisms and their Targets in Cerebral Ischemia Models |
| Q37217572 | Increased Expression of mir-34a-5p and Clinical Association in Acute Ischemic Stroke Patients and in a Rat Model. |
| Q88984348 | Inhibition of miR-141-3p Ameliorates the Negative Effects of Poststroke Social Isolation in Aged Mice |
| Q64092197 | Inhibition of microRNA-103a inhibits the activation of astrocytes in hippocampus tissues and improves the pathological injury of neurons of epilepsy rats by regulating BDNF |
| Q37365653 | Inhibition of microRNA-181 reduces forebrain ischemia-induced neuronal loss |
| Q36669580 | Inhibition of microRNA-210 provides neuroprotection in hypoxic-ischemic brain injury in neonatal rats. |
| Q47982210 | Inhibition of microRNA-210 suppresses pro-inflammatory response and reduces acute brain injury of ischemic stroke in mice. |
| Q35753293 | Inhibition of microRNA-497 ameliorates anoxia/reoxygenation injury in cardiomyocytes by suppressing cell apoptosis and enhancing autophagy |
| Q38415488 | Interplay Between Exosomes, microRNAs and Toll-Like Receptors in Brain Disorders |
| Q37059771 | Intracellular and Extracellular miRNAs in Regulation of Angiogenesis Signaling |
| Q39109413 | Ischemia/Reperfusion |
| Q39881747 | Ischemic pre-conditioning alters cerebral microRNAs that are upstream to neuroprotective signaling pathways |
| Q34112461 | Ischemic preconditioning regulates expression of microRNAs and a predicted target, MeCP2, in mouse cortex |
| Q35894897 | Lack of associations between rs2910164 and rs11614913 polymorphisms and the risk of ischemic stroke |
| Q48633917 | Lentivirus-Mediated Overexpression of MicroRNA-210 Improves Long-Term Outcomes after Focal Cerebral Ischemia in Mice |
| Q36737486 | Let-7a gene knockdown protects against cerebral ischemia/reperfusion injury. |
| Q44054300 | Leukocyte response is regulated by microRNA let7i in patients with acute ischemic stroke |
| Q35228795 | Life or death? A physiogenomic approach to understand individual variation in responses to hemorrhagic shock |
| Q47841199 | Long non-coding RNA and microRNA-675/let-7a mediates the protective effect of melatonin against early brain injury after subarachnoid hemorrhage via targeting TP53 and neural growth factor |
| Q57092311 | Long-term exposure to high altitude hypoxia during pregnancy increases fetal heart susceptibility to ischemia/reperfusion injury and cardiac dysfunction |
| Q90290312 | MMP-9-Related microRNAs as Prognostic Markers for Hemorrhagic Transformation in Cardioembolic Stroke Patients |
| Q52670924 | MiR-103 regulates the angiogenesis of ischemic stroke rats by targeting vascular endothelial growth factor (VEGF). |
| Q50861811 | MiR-132 Is Upregulated by Ischemic Preconditioning of Cultured Hippocampal Neurons and Protects them from Subsequent OGD Toxicity. |
| Q91832474 | MiR-191 inhibit angiogenesis after acute ischemic stroke targeting VEZF1 |
| Q55058387 | MiR-204 promotes apoptosis in oxidative stress-induced rat Schwann cells by suppressing neuritin expression. |
| Q35648315 | MiR-335 Regulates Hif-1α to Reduce Cell Death in Both Mouse Cell Line and Rat Ischemic Models |
| Q58576758 | MiR-34a and stroke: Assessment of non-modifiable biological risk factors in cerebral ischemia |
| Q38808277 | MiRNAs: potential diagnostic and therapeutic targets for cerebral ischaemia |
| Q34121520 | MicroRNA 320a functions as a novel endogenous modulator of aquaporins 1 and 4 as well as a potential therapeutic target in cerebral ischemia |
| Q37601818 | MicroRNA dysregulation in spinal cord injury: causes, consequences and therapeutics. |
| Q35033677 | MicroRNA in central nervous system trauma and degenerative disorders |
| Q34137995 | MicroRNA in ischemic stroke etiology and pathology |
| Q64886654 | MicroRNA in the Pathophysiology of CNS Injury: Implication in Neuroregenerative Medicine. |
| Q40977004 | MicroRNA let-7e Is a Potential Circulating Biomarker of Acute Stage Ischemic Stroke |
| Q28570733 | MicroRNA miR-29c down-regulation leading to de-repression of its target DNA methyltransferase 3a promotes ischemic brain damage |
| Q36392115 | MicroRNA miR124 is required for the expression of homeostatic synaptic plasticity. |
| Q33606298 | MicroRNA profiling in ischemic injury of the gracilis muscle in rats |
| Q34009331 | MicroRNA profiling in subventricular zone after stroke: MiR-124a regulates proliferation of neural progenitor cells through Notch signaling pathway |
| Q35105269 | MicroRNA regulation of homeostatic synaptic plasticity |
| Q37575775 | MicroRNA responses to focal cerebral ischemia in male and female mouse brain |
| Q37741192 | MicroRNA signatures in neurological disorders |
| Q64271550 | MicroRNA target gene prediction of ischemic stroke by using variational Bayesian inference for Gauss mixture model |
| Q38311591 | MicroRNA-124 (miR-124) regulates Ku70 expression and is correlated with neuronal death induced by ischemia/reperfusion |
| Q50919336 | MicroRNA-124 protects against focal cerebral ischemia via mechanisms involving Usp14-dependent REST degradation. |
| Q46302086 | MicroRNA-125a-3p is involved in early behavioral disorders in stroke-afflicted rats through the regulation of Cadm2. |
| Q35874426 | MicroRNA-130a represses transcriptional activity of aquaporin 4 M1 promoter |
| Q40135764 | MicroRNA-146a Promotes Oligodendrogenesis in Stroke. |
| Q37544159 | MicroRNA-181c Exacerbates Brain Injury in Acute Ischemic Stroke |
| Q47781954 | MicroRNA-1906, a Novel Regulator of Toll-Like Receptor 4, Ameliorates Ischemic Injury after Experimental Stroke in Mice. |
| Q27321524 | MicroRNA-206: a potential circulating biomarker candidate for amyotrophic lateral sclerosis |
| Q37511094 | MicroRNA-206: a promising theranostic marker. |
| Q90678650 | MicroRNA-21 in the Pathogenesis of Traumatic Brain Injury |
| Q38803646 | MicroRNA-25 Negatively Regulates Cerebral Ischemia/Reperfusion Injury-Induced Cell Apoptosis Through Fas/FasL Pathway |
| Q36350479 | MicroRNA-29b is a therapeutic target in cerebral ischemia associated with aquaporin 4 |
| Q47368576 | MicroRNA-433 Inhibits the Proliferation and Migration of HUVECs and Neurons by Targeting Hypoxia-Inducible Factor 1 Alpha |
| Q49159908 | MicroRNA-9 Mediates the Cell Apoptosis by Targeting Bcl2l11 in Ischemic Stroke |
| Q35578530 | MicroRNA-9: functional evolution of a conserved small regulatory RNA. |
| Q88510369 | MicroRNA-based therapeutics in central nervous system injuries |
| Q59000021 | MicroRNA: Not Far from Clinical Application in Ischemic Stroke |
| Q39076551 | MicroRNA: Relevance to stroke diagnosis, prognosis, and therapy |
| Q26780451 | MicroRNAs Regulate Mitochondrial Function in Cerebral Ischemia-Reperfusion Injury |
| Q64087505 | MicroRNAs and the Genetic Nexus of Brain Aging, Neuroinflammation, Neurodegeneration, and Brain Trauma |
| Q38098095 | MicroRNAs and tumor vasculature normalization: impact on anti-tumor immune response |
| Q37088938 | MicroRNAs as effectors of brain function |
| Q34101214 | MicroRNAs as effectors of brain function with roles in ischemia and injury, neuroprotection, and neurodegeneration |
| Q38272668 | MicroRNAs as potential circulating biomarkers for amyotrophic lateral sclerosis |
| Q38201677 | MicroRNAs expression and function in cerebral ischemia reperfusion injury |
| Q41889408 | MicroRNAs in CNS injury: Potential roles and therapeutic implications |
| Q47599294 | MicroRNAs in Cerebral Ischemia |
| Q36711803 | MicroRNAs in Cerebral Ischemia |
| Q36847079 | MicroRNAs in Hyperglycemia Induced Endothelial Cell Dysfunction |
| Q28382954 | MicroRNAs in Neurotoxicity |
| Q37679588 | MicroRNAs in the Neural Retina |
| Q30587221 | MicroRNAs participate in the murine oligodendroglial response to perinatal hypoxia-ischemia |
| Q37396241 | MicroRNAs regulate the chaperone network in cerebral ischemia |
| Q34594189 | MicroRNAs: Meta-controllers of gene expression in synaptic activity emerge as genetic and diagnostic markers of human disease |
| Q38027374 | MicroRNAs: a light into the "black box" of neuropediatric diseases? |
| Q36443626 | MicroRNAs: a novel promising therapeutic target for cerebral ischemia/reperfusion injury? |
| Q35071551 | MicroRNAs: new biomarkers and therapeutic targets after cardiac arrest? |
| Q34244568 | MicroRNAs: novel regulators of oligodendrocyte differentiation and potential therapeutic targets in demyelination-related diseases. |
| Q41869127 | Mir-592 regulates the induction and cell death-promoting activity of p75NTR in neuronal ischemic injury |
| Q37866984 | Molecular markers and mechanisms of stroke: RNA studies of blood in animals and humans. |
| Q47124231 | Neural Vascular Mechanism for the Cerebral Blood Flow Autoregulation after Hemorrhagic Stroke. |
| Q37123385 | Neuroprotectants in stroke therapy |
| Q38165634 | Neuroprotection by astrocytes in brain ischemia: importance of microRNAs |
| Q37190827 | Neuroprotection induced by post-conditioning following ischemia/reperfusion in mice is associated with altered microRNA expression |
| Q37341903 | Neuroprotective Effect of Hydrogen-Rich Saline in Global Cerebral Ischemia/Reperfusion Rats: Up-Regulated Tregs and Down-Regulated miR-21, miR-210 and NF-κB Expression. |
| Q48464673 | Neuroprotective effect of ischemic preconditioning via modulating the expression of cerebral miRNAs against transient cerebral ischemia in diabetic rats |
| Q44066855 | Neuroprotective effects of microRNA-210 on hypoxic-ischemic encephalopathy |
| Q33772089 | Non-Coding RNAs as Potential Neuroprotectants against Ischemic Brain Injury |
| Q28082190 | Non-Coding RNAs in Stroke and Neuroprotection |
| Q39107969 | Non-coding RNAs and neuroprotection after acute CNS injuries. |
| Q38796155 | Non-coding RNAs as Emerging Regulators of Neural Injury Responses and Regeneration |
| Q52594573 | Noncoding RNAs and Stroke. |
| Q36673371 | Novel functions for small RNA molecules |
| Q41534007 | Overexpression of miR-210 and its significance in ischemic tissue damage. |
| Q47987561 | Plasma miR-124 Is a Promising Candidate Biomarker for Human Intracerebral Hemorrhage Stroke |
| Q34155097 | Plasma miR-216a as a potential marker of pancreatic injury in a rat model of acute pancreatitis |
| Q58722282 | Plasma microRNA markers of upper limb recovery following human stroke |
| Q36185344 | Post-insult valproic acid-regulated microRNAs: potential targets for cerebral ischemia |
| Q48020770 | Potential of microRNAs as novel targets in the alleviation of pathological fear |
| Q38085380 | Potential roles of HDAC inhibitors in mitigating ischemia-induced brain damage and facilitating endogenous regeneration and recovery. |
| Q89861390 | Preeclampsia: The Interplay Between Oxygen-Sensitive miRNAs and Erythropoietin |
| Q39684610 | Proteomic analysis of rat plasma following transient focal cerebral ischemia |
| Q38103359 | RNA-based blood genomics as an investigative tool and prospective biomarker for ischemic stroke |
| Q34425017 | ROD1 is a seedless target gene of hypoxia-induced miR-210. |
| Q34660735 | Rapid regulation of microRNA following induction of long-term potentiation in vivo |
| Q34228292 | Rapid release of tissue enzymes into blood after blast exposure: potential use as biological dosimeters |
| Q35576268 | Regulation of microRNAs miR-30a and miR-143 in cerebral vasculature after experimental subarachnoid hemorrhage in rats. |
| Q47649105 | Relationship of Circulating miRNAs with Insulin Sensitivity and Associated Metabolic Risk Factors in Humans |
| Q34496903 | Renal stromal miRNAs are required for normal nephrogenesis and glomerular mesangial survival. |
| Q34323222 | Repetitive transcranial magnetic stimulation promotes neural stem cell proliferation via the regulation of MiR-25 in a rat model of focal cerebral ischemia |
| Q27012615 | Revisiting the timing hypothesis: biomarkers that define the therapeutic window of estrogen for stroke |
| Q91940323 | Role of rno-miR-124-3p in regulating MCT1 expression in rat brain after permanent focal cerebral ischemia |
| Q33652945 | Role of specific microRNAs for endothelial function and angiogenesis |
| Q42124782 | Screening of Critical Genes and MicroRNAs in Blood Samples of Patients with Ruptured Intracranial Aneurysms by Bioinformatic Analysis of Gene Expression Data. |
| Q36210966 | Serum miR-26a as a diagnostic and prognostic biomarker in cholangiocarcinoma |
| Q47276687 | Sex differences in the brain: Implications for behavioral and biomedical research. |
| Q35920799 | Sexual dimorphism in miR-210 expression and mitochondrial dysfunction in the placenta with maternal obesity. |
| Q34159796 | Species-specific microRNA roles elucidated following astrocyte activation. |
| Q40294298 | Stroke and Circulating Extracellular RNAs |
| Q38789375 | Stroke in Women: Risk Factors and Clinical Biomarkers. |
| Q36224362 | Stroke-induced microRNAs: The potential therapeutic role for stroke |
| Q36961798 | Synergy of homocysteine, microRNA, and epigenetics: a novel therapeutic approach for stroke |
| Q52667954 | Systematic Analysis of RNA Regulatory Network in Rat Brain after Ischemic Stroke. |
| Q33836761 | Temporal differences in microRNA expression patterns in astrocytes and neurons after ischemic injury |
| Q38740709 | The Emerging Role of Epigenetics in Cerebral Ischemia |
| Q39324614 | The Interplay of MicroRNAs in the Inflammatory Mechanisms Following Ischemic Stroke |
| Q42079307 | The MicroRNAs and Stroke: No Need to be Coded to be Counted |
| Q92257585 | The Potential Role of MicroRNA-124 in Cerebral Ischemia Injury |
| Q88998651 | The Roles of MicroRNAs in Stroke: Possible Therapeutic Targets |
| Q33754641 | The brain-enriched microRNA miR-124 in plasma predicts neurological outcome after cardiac arrest |
| Q38848397 | The effect of chemically modified electrospun silica nanofiber on the mRNA and miRNA expression profile of neural stem cell differentiation |
| Q36886962 | The emerging role of epigenetics in stroke: II. RNA regulatory circuitry |
| Q37128646 | The emerging roles of microRNAs in CNS injuries |
| Q48028137 | The epigenetic component of the brain response to electromagnetic stimulation in Parkinson's Disease patients: A literature overview |
| Q27024466 | The interplay between microRNAs and histone deacetylases in neurological diseases |
| Q38879224 | The interplay of microRNAs and post-ischemic glutamate excitotoxicity: an emergent research field in stroke medicine |
| Q90411651 | The microRNA miR-7a-5p ameliorates ischemic brain damage by repressing α-synuclein |
| Q34356918 | The myriad essential roles of microRNAs in cardiovascular homeostasis and disease |
| Q42560220 | The ongoing microRNA revolution and its impact in biology and medicine |
| Q33907827 | The role of circulating microRNA-126 (miR-126): a novel biomarker for screening prediabetes and newly diagnosed type 2 diabetes mellitus |
| Q37376129 | The therapeutic potential of microRNAs in nervous system damage, degeneration, and repair. |
| Q27015999 | The transcriptome of cerebral ischemia |
| Q38172986 | The use of microRNAs to modulate redox and immune response to stroke |
| Q32175632 | Thrombin-induced, TNFR-dependent miR-181c downregulation promotes MLL1 and NF-κB target gene expression in human microglia |
| Q35885037 | Time-Course Analysis of Brain Regional Expression Network Responses to Chronic Intermittent Ethanol and Withdrawal: Implications for Mechanisms Underlying Excessive Ethanol Consumption |
| Q34580474 | Toll-like receptor tolerance as a mechanism for neuroprotection. |
| Q38997880 | Transcriptional profiling reveals that C5a alters microRNA in brain endothelial cells |
| Q41979112 | Transient focal ischemia induces extensive temporal changes in rat cerebral microRNAome |
| Q48820480 | Traumatic brain injury alters expression of hippocampal microRNAs: potential regulators of multiple pathophysiological processes |
| Q48709031 | Up-regulation of brain-enriched miR-107 promotes excitatory neurotoxicity through down-regulation of glutamate transporter-1 expression following ischaemic stroke |
| Q28265872 | Using exosomes, naturally-equipped nanocarriers, for drug delivery |
| Q53581420 | [Role of miRNA-210 in hypoxic-ischemic brain edema in neonatal rats]. |
| Q93342021 | miR-128b Promotes Cerebral Infarction by Regulating the Expressions of BCL-2 and CAPASE3 |
| Q38957856 | miR-137, a new target for post-stroke depression? |
| Q47148529 | miR-145-5p/Nurr1/TNF-α Signaling-Induced Microglia Activation Regulates Neuron Injury of Acute Cerebral Ischemic/Reperfusion in Rats |
| Q88127820 | miR-146a and miR-196a2 polymorphisms in patients with ischemic stroke in the northern Chinese Han population |
| Q89849879 | miR-155 Knockdown Protects against Cerebral Ischemia and Reperfusion Injury by Targeting MafB |
| Q40159726 | miR-181 regulates GRP78 and influences outcome from cerebral ischemia in vitro and in vivo |
| Q35649100 | miR-181 targets multiple Bcl-2 family members and influences apoptosis and mitochondrial function in astrocytes. |
| Q90402147 | miR-183 inhibits microglia activation and expression of inflammatory factors in rats with cerebral ischemia reperfusion via NF-κB signaling pathway |
| Q48397272 | miR-206 regulates brain-derived neurotrophic factor in Alzheimer disease model |
| Q44371271 | miR-210 activates notch signaling pathway in angiogenesis induced by cerebral ischemia |
| Q28306244 | miR-210: More than a silent player in hypoxia |
| Q35891149 | miR-210: fine-tuning the hypoxic response |
| Q35105106 | miR-23a regulation of X-linked inhibitor of apoptosis (XIAP) contributes to sex differences in the response to cerebral ischemia |
| Q39411578 | miR-376b controls starvation and mTOR inhibition-related autophagy by targeting ATG4C and BECN1. |
| Q48602002 | miRNA expression profiles in cerebrospinal fluid and blood of patients with acute ischemic stroke |
| Q38474027 | miRNA functional synergistic network analysis of mice with ischemic stroke |
| Q38110520 | miRNA in the regulation of ion channel/transporter expression |
| Q64082895 | miRNA profiling of urinary exosomes to assess the progression of acute kidney injury |
| Q35078172 | miRNAs-19b, -29b-2* and -339-5p show an early and sustained up-regulation in ischemic models of stroke |
| Q33541316 | miRSel: automated extraction of associations between microRNAs and genes from the biomedical literature |
| Q64232724 | miR‑29a ameliorates ischemic injury of astrocytes in vitro by targeting the water channel protein aquaporin 4 |
| Q33728647 | microRNA expression in peripheral blood cells following acute ischemic stroke and their predicted gene targets |
| Q58694481 | microRNA-451 protects neurons against ischemia/reperfusion injury-induced cell death by targeting CELF2 |
| Q34792605 | microRNAs Involved in Regulating Spontaneous Recovery in Embolic Stroke Model |
| Q37918622 | microRNAs as peripheral blood biomarkers of cardiovascular disease. |
| Q38668253 | microRNAs in Cerebrovascular Disease. |
| Q27009439 | microRNAs in spinal cord injury: potential roles and therapeutic implications |
| Q36905867 | microRNAs: innovative targets for cerebral ischemia and stroke. |
Search more.